Sunshine Biopharma (SBFM) Change in Receivables (2015 - 2026)
Sunshine Biopharma's (SBFM) quarterly Change in Receivables came in at $609601.0 in Q1 2026, up 242.87% YoY from $177792.0 in Q1 2025, and up 1576.28% on a QoQ basis from -$41293.0 in Q4 2025.
Sunshine Biopharma (SBFM) Change in Receivables (2015 - 2026) Analysis & Trends
Sunshine Biopharma (SBFM) has 10 years of Change in Receivables data on file, last reported at $609601.0 in Q1 2026.
- Quarterly Change in Receivables rose 242.87% year-over-year to $609601.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.2 million (down 16.2% YoY) and the FY2025 annual result came in at $116173.0, down 95.03% from the prior year.
- Change in Receivables rose to $609601.0 in Q1 2026, from -$41293.0 in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $1.8 million in Q2 2024 to a low of -$986986.0 in Q3 2024.
- A 5-year average of $261412.2 and a median of $127186.5 in 2023 frame the typical range for Change in Receivables.
- Annual changes were most pronounced in 2023 — Change in Receivables jumped 3166200.0% — and 2024, when it plunged 1658.68%.
- Tracing SBFM's Change in Receivables over 5 years: stood at $532262.0 in 2022, then fell by 10.63% to $475659.0 in 2023, then surged by 113.81% to $1.0 million in 2024, then sank by 104.06% to -$41293.0 in 2025, then surged by 1576.28% to $609601.0 in 2026.
- The last three Change in Receivables figures came in at $609601.0 (Q1 2026), -$41293.0 (Q4 2025), and $649850.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 91.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 66.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -445.26 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -1.70 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 126.50 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 84.30 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Sunshine Biopharma | 1.58 Mn | -12.17 Mn | 2.43 Mn | 88,610.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 88,610.00 |
| Jun 30, 2026 | 88,610.00 |
| Mar 31, 2026 | 609,601.00 |
| Mar 31, 2026 | 609,601.00 |
| Dec 31, 2025 | -41,293.00 |
| Dec 31, 2025 | -41,293.00 |
| Sep 30, 2025 | 649,850.00 |
| Sep 30, 2025 | 649,850.00 |
| Jun 30, 2025 | -65,711.00 |
| Jun 30, 2025 | -65,711.00 |
| Mar 31, 2025 | -426,673.00 |
| Mar 31, 2025 | -426,673.00 |
| Dec 31, 2024 | 1.02 Mn |
| Dec 31, 2024 | 1.02 Mn |
| Sep 30, 2024 | -986,986.00 |
| Sep 30, 2024 | -986,986.00 |
| Jun 30, 2024 | 1.77 Mn |
| Jun 30, 2024 | 1.77 Mn |
| Mar 31, 2024 | 536,261.00 |
| Mar 31, 2024 | 536,261.00 |